What is Zacks Research’s Forecast for McKesson Q2 Earnings?

McKesson Co. (NYSE:MCK) – Research analysts at Zacks Research lowered their Q2 2025 earnings per share estimates for shares of McKesson in a research note issued to investors on Tuesday, October 22nd. Zacks Research analyst R. Department now anticipates that the company will post earnings per share of $6.97 for the quarter, down from their previous estimate of $7.11. The consensus estimate for McKesson’s current full-year earnings is $32.07 per share. Zacks Research also issued estimates for McKesson’s Q3 2025 earnings at $8.24 EPS, Q4 2025 earnings at $8.88 EPS, FY2025 earnings at $31.97 EPS, Q1 2026 earnings at $7.86 EPS, Q3 2026 earnings at $9.85 EPS and Q4 2026 earnings at $8.95 EPS.

Several other equities analysts have also issued reports on the company. Evercore ISI decreased their price target on McKesson from $660.00 to $630.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. JPMorgan Chase & Co. lifted their price target on McKesson from $656.00 to $661.00 and gave the company an “overweight” rating in a research note on Wednesday, August 21st. Mizuho lifted their price target on McKesson from $540.00 to $570.00 and gave the company a “neutral” rating in a research note on Thursday, August 8th. Baird R W lowered McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 24th. Finally, Barclays boosted their price objective on McKesson from $596.00 to $616.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $610.86.

McKesson Stock Performance

Shares of MCK opened at $507.41 on Thursday. McKesson has a 52-week low of $431.35 and a 52-week high of $637.51. The business’s fifty day moving average is $517.48 and its 200-day moving average is $551.05. The firm has a market cap of $65.93 billion, a price-to-earnings ratio of 22.67, a PEG ratio of 1.17 and a beta of 0.44.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $7.88 earnings per share for the quarter, beating the consensus estimate of $7.21 by $0.67. The firm had revenue of $79.28 billion during the quarter, compared to analysts’ expectations of $82.53 billion. McKesson had a negative return on equity of 242.57% and a net margin of 0.94%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $7.27 EPS.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in MCK. Swedbank AB acquired a new position in shares of McKesson in the 1st quarter valued at about $669,326,000. International Assets Investment Management LLC lifted its stake in shares of McKesson by 1,020.2% in the 3rd quarter. International Assets Investment Management LLC now owns 806,878 shares of the company’s stock valued at $398,937,000 after purchasing an additional 734,849 shares during the period. Bessemer Group Inc. lifted its stake in shares of McKesson by 3,621.7% in the 1st quarter. Bessemer Group Inc. now owns 349,395 shares of the company’s stock valued at $187,572,000 after purchasing an additional 340,007 shares during the period. Bristol Gate Capital Partners Inc. acquired a new position in shares of McKesson in the 1st quarter valued at about $97,510,000. Finally, Assenagon Asset Management S.A. raised its stake in McKesson by 581.0% during the 3rd quarter. Assenagon Asset Management S.A. now owns 151,240 shares of the company’s stock worth $74,776,000 after buying an additional 129,031 shares during the period. 85.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at McKesson

In other McKesson news, CEO Brian S. Tyler sold 3,753 shares of the company’s stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $561.10, for a total value of $2,105,808.30. Following the sale, the chief executive officer now owns 78,586 shares in the company, valued at approximately $44,094,604.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.11% of the company’s stock.

McKesson Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 1st. Shareholders of record on Monday, September 2nd were given a $0.71 dividend. This represents a $2.84 dividend on an annualized basis and a dividend yield of 0.56%. The ex-dividend date of this dividend was Friday, August 30th. This is a positive change from McKesson’s previous quarterly dividend of $0.62. McKesson’s payout ratio is 12.69%.

About McKesson

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.